Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation

Obesity Research

Volumn 11, Issue 3, 2003, Pages 403-407

  Samocha Bonet, Dorit ^a,b   Lichtenberg, Dov ^b   Tomer, Aaron ^c   Deutsch, Varda ^a   Mardi, Tamar ^a   Goldin, Yelena ^a   Abu Abeid, Subchi ^a   Shenkerman, Galina ^a   Patshomik, Hana ^a   Shapira, Itzhak ^a   Berliner, Shlomo ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Erythrocyte aggregability; Inflammation markers; Phosphatidylserine

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLSERINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; BODY CONSTITUTION; BODY MASS; CELL ADHESION; CHEMISTRY; COMPARATIVE STUDY; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE MEMBRANE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; OBESITY; PHYSIOLOGY;

ADULT; BLOOD SEDIMENTATION; BODY CONSTITUTION; BODY MASS INDEX; C-REACTIVE PROTEIN; CELL ADHESION; CHOLESTEROL, HDL; ERYTHROCYTE AGGREGATION; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; OBESITY; PHOSPHATIDYLSERINES; TRIGLYCERIDES;

EID: 0037870119     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.54     Document Type: Article

References (28)

1. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635-43.
2. Lemieux I, Pascot A, Prud'homme D, et al. Elevated C-reactive protein - another component of the atherothrombotic profile of abdominal obesity. Artheriosc Thromb Vasc Biol. 2001;21:961-7.
3. Ford ES. Body mass index, diabetes and C-reactive protein among US adults. Diabetes Care. 1999;22:1971-7.
4. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance. Science. 1993;259:87-91.
5. de Maat MP, Pietersma A, Kofflard M, Sluiter W, Kluft C. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis. 1996;121:185-91.
6. Imaizumi K, Shiga T. Effect of immunoglobulins and IgG-fragments on the human erythrocyte aggregation, studied by rheoscope combined with image analyzer. Biorheology. 1983;20:569-77.
7. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Eng J Med. 1999;340:448-54.
8. Dalakas MC. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology. 1994;44:223-6.
9. Rampling MW, Whittingstall P, Linderkamp O. The effects of fibrinogen and its plasmin degradation products on the rheology of erythrocyte suspensions. Clin Hemorheol. 1984;4:533-43.
10. Weng X, Roederer GO, Beaulieu R, Cloutier G. Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals. Thromb Haemost. 1998;80:903-8.
11. Vaya A, Martinez M, Carmena R, Aznar J. Red blood cell aggregation and primary hyperlipoproteinemia. Thromb Res. 1993;72:119-26.
12. 2+ content, and erythrocyte membrane dynamic properties. Microvasc Res. 1993;46:401-5.
13. Ravazian SM, Del Pino M, Simon A, Levenson J. Increase in erythrocyte disaggregation shear stress in hypertension. Hypertension. 1992;20:247-52.
14. Valensi P, Paries J, Maheo P, Gaudey F, Attali JR. Erythrocyte rheological changes in obese patients: influence of hyperinsulinism. Int J Obes Relat Metab Disord. 1996;20:814-9.
15. Caimi G, Lo-Presti R, Serra A, et al. Rheological determinants and red cell lipidic pattern in essential obesity, in obese subjects with non-insulin dependent diabetes mellitus and in obese subjects with impaired glucose tolerance. Microcirc Endothelium Lymphatics. 1991;7:293-304.
16. Soutani M, Suzuki Y, Tateishi N, Maeda N. Quantitative evaluation of flow dynamics of erythrocytes in microvessels: influence of erythrocyte aggregation. Am J Physiol. 1995;268:H1959-H65.
17. Sambrano GR, Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA. 1995;92:1396-400.
18. Rotstein R, Landau T, Twig A, et al. The erythrocyte adhesiveness/ aggregation test (EAAT). A new biomarker to reveal the low grade subclinical smoldering inflammation in individuals with atherosclerotic risk factors. Atherosclerosis. 2002;165:343-51.
19. Fusman G, Mardi T, Justo D, et al. Red blood cell adhesiveness/ aggregation, C-reactive protein, fibrinogen and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol. 2002;90:561-3.
20. International Committee for Standardization in Hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry. 1965;2:235-54.
21. Clauss A. Gerinnungsphysiologische Shnellmethode zur Bestimmung des Fibrinogens. Acta Haematol Basel. 1957;17:237-46.
22. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem. 1999;45:2136-41.
23. Tomer A, Harker LA, Kasey S, Eckman JR. Thrombogenesis in sickle cell disease. J Lab Clin Med. 2001;137:398-407.
24. Nieman DC, Nehlsen-Cannarella SL, Henson DA, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353-60.
25. Nieman DC, Henson DA, Nehlsen-Cannarella SL, et al. Influence of obesity on immune function. J Am Diet Assoc. 1999;99:294-9.
26. Déspres JP. The insulin resistance dyslipidemic syndrome of visceral obesity: effect on patient's risk. Obes Res. 1998;6(suppl):8S-17S.
27. Ben Ami R, Barshtein G, Zeltser D, et al. Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol. 2001;280:H1982-H8.
28. Pfafferott C, Moessmer G, Ehrly AM, Bauersachs RM. Involvement of erythrocyte aggregation and erythrocyte resistance to flow in acute coronary syndromes. Clin Hemorheol Microcirc. 1999;21:35-43.